725 related articles for article (PubMed ID: 32974337)
21. The role of vascular endothelial growth factor in the hypoxic and immunosuppressive tumor microenvironment: perspectives for therapeutic implications.
Tamura R; Tanaka T; Akasaki Y; Murayama Y; Yoshida K; Sasaki H
Med Oncol; 2019 Nov; 37(1):2. PubMed ID: 31713115
[TBL] [Abstract][Full Text] [Related]
22. The Microenvironment of Lung Cancer and Therapeutic Implications.
Mittal V; El Rayes T; Narula N; McGraw TE; Altorki NK; Barcellos-Hoff MH
Adv Exp Med Biol; 2016; 890():75-110. PubMed ID: 26703800
[TBL] [Abstract][Full Text] [Related]
23. The Role of Tumor-Stroma Interactions in Drug Resistance Within Tumor Microenvironment.
Ni Y; Zhou X; Yang J; Shi H; Li H; Zhao X; Ma X
Front Cell Dev Biol; 2021; 9():637675. PubMed ID: 34095111
[TBL] [Abstract][Full Text] [Related]
24. Engineering Nanoparticles for Targeted Remodeling of the Tumor Microenvironment to Improve Cancer Immunotherapy.
Gao S; Yang D; Fang Y; Lin X; Jin X; Wang Q; Wang X; Ke L; Shi K
Theranostics; 2019; 9(1):126-151. PubMed ID: 30662558
[TBL] [Abstract][Full Text] [Related]
25. Role of cancer-associated fibroblast subpopulations in immune infiltration, as a new means of treatment in cancer.
Mhaidly R; Mechta-Grigoriou F
Immunol Rev; 2021 Jul; 302(1):259-272. PubMed ID: 34013544
[TBL] [Abstract][Full Text] [Related]
26. Natural Killer Cells as Key Players of Tumor Progression and Angiogenesis: Old and Novel Tools to Divert Their Pro-Tumor Activities into Potent Anti-Tumor Effects.
Bassani B; Baci D; Gallazzi M; Poggi A; Bruno A; Mortara L
Cancers (Basel); 2019 Apr; 11(4):. PubMed ID: 30939820
[No Abstract] [Full Text] [Related]
27. Tumor endothelial cell autophagy is a key vascular-immune checkpoint in melanoma.
Verhoeven J; Jacobs KA; Rizzollo F; Lodi F; Hua Y; Poźniak J; Narayanan Srinivasan A; Houbaert D; Shankar G; More S; Schaaf MB; Dubroja Lakic N; Ganne M; Lamote J; Van Weyenbergh J; Boon L; Bechter O; Bosisio F; Uchiyama Y; Bertrand MJ; Marine JC; Lambrechts D; Bergers G; Agrawal M; Agostinis P
EMBO Mol Med; 2023 Dec; 15(12):e18028. PubMed ID: 38009521
[TBL] [Abstract][Full Text] [Related]
28. MicroRNAs in the Tumor Microenvironment.
Patil N; Allgayer H; Leupold JH
Adv Exp Med Biol; 2020; 1277():1-31. PubMed ID: 33119862
[TBL] [Abstract][Full Text] [Related]
29. Metformin inhibits esophageal squamous cell carcinoma-induced angiogenesis by suppressing JAK/STAT3 signaling pathway.
Yang Y; Jin G; Liu H; Liu K; Zhao J; Chen X; Wang D; Bai R; Li X; Jang Y; Lu J; Xing Y; Dong Z
Oncotarget; 2017 Sep; 8(43):74673-74687. PubMed ID: 29088816
[TBL] [Abstract][Full Text] [Related]
30. Endothelial Heme Dynamics Drive Cancer Cell Metabolism by Shaping the Tumor Microenvironment.
Petrillo S; De Giorgio F; Kopecka J; Genova T; Fiorito V; Allocco AL; Bertino F; Chiabrando D; Mussano F; Altruda F; Munaron L; Riganti C; Tolosano E
Biomedicines; 2021 Oct; 9(11):. PubMed ID: 34829786
[TBL] [Abstract][Full Text] [Related]
31. ROS enhance angiogenic properties via regulation of NRF2 in tumor endothelial cells.
Hojo T; Maishi N; Towfik AM; Akiyama K; Ohga N; Shindoh M; Hida Y; Minowa K; Fujisawa T; Hida K
Oncotarget; 2017 Jul; 8(28):45484-45495. PubMed ID: 28525375
[TBL] [Abstract][Full Text] [Related]
32. Development of Immortalized Human Tumor Endothelial Cells from Renal Cancer.
Maishi N; Kikuchi H; Sato M; Nagao-Kitamoto H; Annan DA; Baba S; Hojo T; Yanagiya M; Ohba Y; Ishii G; Masutomi K; Shinohara N; Hida Y; Hida K
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31533313
[TBL] [Abstract][Full Text] [Related]
33. Contribution of Tumor Endothelial Cells in Cancer Progression.
Hida K; Maishi N; Annan DA; Hida Y
Int J Mol Sci; 2018 Apr; 19(5):. PubMed ID: 29695087
[TBL] [Abstract][Full Text] [Related]
34. Cancer Cell Metabolism Bolsters Immunotherapy Resistance by Promoting an Immunosuppressive Tumor Microenvironment.
Jiang Z; Hsu JL; Li Y; Hortobagyi GN; Hung MC
Front Oncol; 2020; 10():1197. PubMed ID: 32775303
[TBL] [Abstract][Full Text] [Related]
35. B Cell Orchestration of Anti-tumor Immune Responses: A Matter of Cell Localization and Communication.
Kinker GS; Vitiello GAF; Ferreira WAS; Chaves AS; Cordeiro de Lima VC; Medina TDS
Front Cell Dev Biol; 2021; 9():678127. PubMed ID: 34164398
[TBL] [Abstract][Full Text] [Related]
36. Expression of B7-H1 in inflammatory renal tubular epithelial cells.
Chen Y; Zhang J; Li J; Zou L; Zhao T; Tang Y; Wu Y
Nephron Exp Nephrol; 2006; 102(3-4):e81-92. PubMed ID: 16282703
[TBL] [Abstract][Full Text] [Related]
37. Tumor microenvironment (TME)-driven immune suppression in B cell malignancy.
Nicholas NS; Apollonio B; Ramsay AG
Biochim Biophys Acta; 2016 Mar; 1863(3):471-482. PubMed ID: 26554850
[TBL] [Abstract][Full Text] [Related]
38. Exploring the crosstalk between endothelial cells, immune cells, and immune checkpoints in the tumor microenvironment: new insights and therapeutic implications.
Fang J; Lu Y; Zheng J; Jiang X; Shen H; Shang X; Lu Y; Fu P
Cell Death Dis; 2023 Sep; 14(9):586. PubMed ID: 37666809
[TBL] [Abstract][Full Text] [Related]
39. Communicator Extraordinaire: Extracellular Vesicles in the Tumor Microenvironment Are Essential Local and Long-Distance Mediators of Cancer Metastasis.
Mitchell MI; Loudig O
Biomedicines; 2023 Sep; 11(9):. PubMed ID: 37760975
[TBL] [Abstract][Full Text] [Related]
40. Single-cell transcriptomics reveals antigen-presenting capacity and therapeutic resistance potential of immunomodulatory endothelial cells in colorectal cancer.
Wen J
Immun Inflamm Dis; 2024 Jun; 12(6):e1311. PubMed ID: 38874280
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
